tip

tip

TIP A COLLEAGUE

Key publications

Onset of action within depression

Using meta-regression in performing indirectcomparisons: comparing escitalopram with venlafaxine XR

Eckert et al. Curr Med Res Opin 2006; 22(11): 2313-2321

Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care

Lepola et al., International Clinical Psychopharmacology 2003; 18:211-217

Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder

Lepola et al., International Clinical Psychopharmacology 2004, 19:149-155

Efficacy of escitalopram in patients with severe depression: a pooled analysis

Llorca, International Journal of Clinical Practice 2005; 59:268-275

Escitalopram versus venlafaxine XR in the treatment of depression

Montgomery Int Clin Psychopharmacol 2006;21: 297-309

Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model

Montgomery et al., Pharmacology & Toxicology 2001;88:282-286

A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder

Montgomery et al., Neuropsychobiology 2004;50:57-64

Escitalopram and suicidality in adult depression and anxiety

Pedersen et al., International Clinical Psychopharmacology 2005; 20: 139-143

The onset of effect for escitalopram and its relevance for the clinical management of depression

Wade et al. Curr Med Res Opin 2006; 22(11): 2101-2110

Published: 22/05/2006 Last updated: 27/07/2010

www.irecover.com www.mypdinfo.com www.ebixa.com www.azilect.com www.serdolect.com www.depnet.com Disclaimer

H. Lundbeck A/S - Ottiliavej 9 - DK-2500 Copenhagen Valby - Phone +45 3630 1311 - Contact us